| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |